Metabolic basis of high density lipoproteins and apolipoprotein A-I increase by HMG-CoA reductase inhibition in healthy subjects and a patient with coronary artery disease.

Source:http://linkedlifedata.com/resource/pubmed/id/10381291

Download in:

View as

General Info

PMID
10381291